Ranbaxy to market S Korean product

Ranbaxy Laboratories Ltd has entered into an in-licencing agreement with South Korean biotech firm Medy-Tox Inc for supply of its dermatology product Neuronox in the Indian market.

The cosmetic use of Neuronox in the correction of facial wrinkles and hyperhidrosis (medical term for excessive sweating), has become one of the most popular cosmetic procedures worldwide.